{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "18617681", "DateCompleted": {"Year": "2008", "Month": "11", "Day": "28"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1165/rcmb.2008-0045OC"], "ArticleDate": [{"Year": "2008", "Month": "07", "Day": "10"}], "Journal": {"ISSN": "1535-4989", "JournalIssue": {"Volume": "39", "Issue": "6", "PubDate": {"Year": "2008", "Month": "Dec"}}, "Title": "American journal of respiratory cell and molecular biology", "ISOAbbreviation": "Am J Respir Cell Mol Biol"}, "ArticleTitle": "IL-1 receptors mediate persistent, but not acute, airway hyperreactivity to ozone in guinea pigs.", "Pagination": {"StartPage": "730", "EndPage": "738", "MedlinePgn": "730-8"}, "Abstract": {"AbstractText": ["Ozone exposure in the lab and environment causes airway hyperreactivity lasting at least 3 days in humans and animals. In guinea pigs 1 day after ozone exposure, airway hyperreactivity is mediated by eosinophils that block neuronal M(2) muscarinic receptor function, thus increasing acetylcholine release from airway parasympathetic nerves. However, mechanisms of ozone-induced airway hyperreactivity change over time, so that depleting eosinophils 3 days after ozone makes airway hyperreactivity worse rather than better. Ozone exposure increases IL-1beta in bone marrow, which may contribute to acute and chronic airway hyperreactivity. To test whether IL-1beta mediates ozone-induced airway hyperreactivity 1 and 3 days after ozone exposure, guinea pigs were pretreated with an IL-1 receptor antagonist (anakinra, 30 mg/kg, intraperitoneally) 30 minutes before exposure to filtered air or to ozone (2 ppm, 4 h). One or three days after exposure, airway reactivity was measured in anesthetized guinea pigs. The IL-1 receptor antagonist prevented ozone-induced airway hyperreactivity 3 days, but not 1 day, after ozone exposure. Ozone-induced airway hyperreactivity was vagally mediated, since bronchoconstriction induced by intravenous acetylcholine was not changed by ozone. The IL-1 receptor antagonist selectively prevented ozone-induced reduction of eosinophils around nerves and prevented ozone-induced deposition of extracellular eosinophil major basic protein in airways. These data demonstrate that IL-1 mediates ozone-induced airway hyperreactivity at 3 days, but not 1 day, after ozone exposure. Furthermore, preventing hyperreactivity was accompanied by decreased eosinophil major basic protein deposition within the lung, suggesting that IL-1 affects eosinophil activation 3 days after ozone exposure."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, Oregon 97239, USA."}], "Identifier": [], "LastName": "Verhein", "ForeName": "Kirsten C", "Initials": "KC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jacoby", "ForeName": "David B", "Initials": "DB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Fryer", "ForeName": "Allison D", "Initials": "AD"}], "GrantList": [{"GrantID": "HL-55543", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "HL-54659", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "RR-023424", "Acronym": "RR", "Agency": "NCRR NIH HHS", "Country": "United States"}, {"GrantID": "HL-071795", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "ES-014601", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Respir Cell Mol Biol", "NlmUniqueID": "8917225", "ISSNLinking": "1044-1549"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Interleukin-1beta"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Interleukin-1"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "EC 3.1.27.-", "NameOfSubstance": "Eosinophil Major Basic Protein"}, {"RegistryNumber": "N9YNS0M02X", "NameOfSubstance": "Acetylcholine"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Acetylcholine"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Bone Marrow"}, {"QualifierName": ["complications"], "DescriptorName": "Bradycardia"}, {"QualifierName": ["complications", "metabolism", "physiopathology"], "DescriptorName": "Bronchial Hyperreactivity"}, {"QualifierName": [], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": [], "DescriptorName": "Electric Stimulation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Eosinophil Major Basic Protein"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Eosinophils"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Guinea Pigs"}, {"QualifierName": ["drug effects"], "DescriptorName": "Hemodynamics"}, {"QualifierName": ["pathology"], "DescriptorName": "Inflammation"}, {"QualifierName": [], "DescriptorName": "Injections, Intravenous"}, {"QualifierName": ["metabolism"], "DescriptorName": "Interleukin-1beta"}, {"QualifierName": [], "DescriptorName": "Models, Biological"}, {"QualifierName": ["drug effects"], "DescriptorName": "Muscle Contraction"}, {"QualifierName": ["drug effects"], "DescriptorName": "Muscle, Smooth"}, {"QualifierName": ["drug effects", "pathology"], "DescriptorName": "Neutrophils"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Receptors, Interleukin-1"}, {"QualifierName": ["drug effects"], "DescriptorName": "Vagus Nerve"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Shore SA, Schwartzman IN, Le Blanc B, Murthy GG, Doerschuk CM. Tumor necrosis factor receptor 2 contributes to ozone-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med 2001;164:602\u2013607.", "ArticleIdList": ["11520723"]}, {"Citation": "Bell ML, McDermott A, Zeger SL, Samet JM, Dominici F. Ozone and short-term mortality in 95 US urban communities, 1987\u20132000. JAMA 2004;292:2372\u20132378.", "ArticleIdList": ["PMC3546819", "15547165"]}, {"Citation": "Yost BL, Gleich GJ, Jacoby DB, Fryer AD. The changing role of eosinophils in long-term hyperreactivity following a single ozone exposure. Am J Physiol Lung Cell Mol Physiol 2005;289:L627\u2013L635.", "ArticleIdList": ["15923207"]}, {"Citation": "Lewis TC, Robins TG, Dvonch JT, Keeler GJ, Yip FY, Mentz GB, Lin X, Parker EA, Israel BA, Gonzalez L, et al. Air pollution-associated changes in lung function among asthmatic children in Detroit. Environ Health Perspect 2005;113:1068\u20131075.", "ArticleIdList": ["PMC1280351", "16079081"]}, {"Citation": "Ko FW, Tam WW, Chan DP, Wong T, Tung AH, Lai CK, Hui DS. The temporal relationship between air pollutants and hospital admissions for chronic obstructive pulmonary disease in Hong Kong. Thorax 2007;62:780\u2013785.", "ArticleIdList": ["PMC2117326", "17311838"]}, {"Citation": "Hiltermann TJ, de Bruijne CR, Stolk J, Zwinderman AH, Spieksma FT, Roemer W, Steerenberg PA, Fischer PH, van Bree L, Hiemstra PS. Effects of photochemical air pollution and allergen exposure on upper respiratory tract inflammation in asthmatics. Am J Respir Crit Care Med 1997;156:1765\u20131772.", "ArticleIdList": ["9412553"]}, {"Citation": "Peden DB, Boehlecke B, Horstman D, Devlin R. Prolonged acute exposure to 0.16 ppm ozone induces eosinophilic airway inflammation in asthmatic subjects with allergies. J Allergy Clin Immunol 1997;100:802\u2013808.", "ArticleIdList": ["9438490"]}, {"Citation": "Peden DB, Setzer RW Jr, Devlin RB. Ozone exposure has both a priming effect on allergen-induced responses and an intrinsic inflammatory action in the nasal airways of perennially allergic asthmatics. Am J Respir Crit Care Med 1995;151:1336\u20131345.", "ArticleIdList": ["7735583"]}, {"Citation": "Fabbri LM, Aizawa H, Alpert SE, Walters EH, O'Byrne PM, Gold BD, Nadel JA, Holtzman MJ. Airway hyperresponsiveness and changes in cell counts in bronchoalveolar lavage after ozone exposure in dogs. Am Rev Respir Dis 1984;129:288\u2013291.", "ArticleIdList": ["6696327"]}, {"Citation": "Hyde DM, Hubbard WC, Wong V, Wu R, Pinkerton K, Plopper CG. Ozone-induced acute tracheobronchial epithelial injury: relationship to granulocyte emigration in the lung. Am J Respir Cell Mol Biol 1992;6:481\u2013497.", "ArticleIdList": ["1581072"]}, {"Citation": "Ishii Y, Hashimoto K, Nomura A, Sakamoto T, Uchida Y, Ohtsuka M, Hasegawa S, Sagai M. Elimination of neutrophils by apoptosis during the resolution of acute pulmonary inflammation in rats. Lung 1998;176:89\u201398.", "ArticleIdList": ["9500294"]}, {"Citation": "Park JW, Taube C, Joetham A, Takeda K, Kodama T, Dakhama A, McConville G, Allen CB, Sfyroera G, Shultz LD, et al. Complement activation is critical to airway hyperresponsiveness after acute ozone exposure. Am J Respir Crit Care Med 2004;169:726\u2013732.", "ArticleIdList": ["14701711"]}, {"Citation": "Jacoby DB, Gleich GJ, Fryer AD. Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. J Clin Invest 1993;91:1314\u20131318.", "ArticleIdList": ["PMC288101", "8473484"]}, {"Citation": "Evans CM, Fryer AD, Jacoby DB, Gleich GJ, Costello RW. Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. J Clin Invest 1997;100:2254\u20132262.", "ArticleIdList": ["PMC508421", "9410903"]}, {"Citation": "Fryer AD, Maclagan J. Muscarinic inhibitory receptors in pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol 1984;83:973\u2013978.", "ArticleIdList": ["PMC1986990", "6518347"]}, {"Citation": "Fryer AD, Jacoby DB. Function of pulmonary M2 muscarinic receptors in antigen-challenged guinea pigs is restored by heparin and poly-L-glutamate. J Clin Invest 1992;90:2292\u20132298.", "ArticleIdList": ["PMC443381", "1281829"]}, {"Citation": "Yost BL, Gleich GJ, Fryer AD. Ozone-induced hyperresponsiveness and blockade of M2 muscarinic receptors by eosinophil major basic protein. J Appl Physiol 1999;87:1272\u20131278.", "ArticleIdList": ["10517752"]}, {"Citation": "Hestdal K, Ruscetti FW, Chizzonite R, Ortiz M, Gooya JM, Longo DL, Keller JR. Interleukin-1 (IL-1) directly and indirectly promotes hematopoietic cell growth through type I IL-1 receptor. Blood 1994;84:125\u2013132.", "ArticleIdList": ["8018912"]}, {"Citation": "Birdsall HH, Lane C, Ramser MN, Anderson DC. Induction of VCAM-1 and ICAM-1 on human neural cells and mechanisms of mononuclear leukocyte adherence. J Immunol 1992;148:2717\u20132723.", "ArticleIdList": ["1374096"]}, {"Citation": "Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996;87:2095\u20132147.", "ArticleIdList": ["8630372"]}, {"Citation": "Jedrzkiewicz S, Nakamura H, Silverman ES, Luster AD, Mansharamani N, In KH, Tamura G, Lilly CM. IL-1beta induces eotaxin gene transcription in A549 airway epithelial cells through NF-kappaB. Am J Physiol Lung Cell Mol Physiol 2000;279:L1058\u2013L1065.", "ArticleIdList": ["11076795"]}, {"Citation": "Okada S, Inoue H, Yamauchi K, Iijima H, Ohkawara Y, Takishima T, Shirato K. Potential role of interleukin-1 in allergen-induced late asthmatic reactions in guinea pigs: suppressive effect of interleukin-1 receptor antagonist on late asthmatic reaction. J Allergy Clin Immunol 1995;95:1236\u20131245.", "ArticleIdList": ["7797792"]}, {"Citation": "Gounni AS, Nutku E, Koussih L, Aris F, Louahed J, Levitt RC, Nicolaides NC, Hamid Q. IL-9 expression by human eosinophils: regulation by IL-1beta and TNF-alpha. J Allergy Clin Immunol 2000;106:460\u2013466.", "ArticleIdList": ["10984364"]}, {"Citation": "Selig W, Tocker J. Effect of interleukin-1 receptor antagonist on antigen-induced pulmonary responses in guinea pigs. Eur J Pharmacol 1992;213:331\u2013336.", "ArticleIdList": ["1377630"]}, {"Citation": "Watson ML, Smith D, Bourne AD, Thompson RC, Westwick J. Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: inhibition of airway hyperreactivity, pulmonary eosinophil accumulation, and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist. Am J Respir Cell Mol Biol 1993;8:365\u2013369.", "ArticleIdList": ["8476630"]}, {"Citation": "Hakonarson H, Carter C, Maskeri N, Hodinka R, Grunstein MM. Rhinovirus-mediated changes in airway smooth muscle responsiveness: induced autocrine role of interleukin-1beta. Am J Physiol 1999;277:L13\u2013L21.", "ArticleIdList": ["10409226"]}, {"Citation": "Johnson VJ, Yucesoy B, Luster MI. Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol 2005;116:851\u2013858.", "ArticleIdList": ["16210060"]}, {"Citation": "Borish L, Mascali JJ, Dishuck J, Beam WR, Martin RJ, Rosenwasser LJ. Detection of alveolar macrophage-derived IL-1 beta in asthma: inhibition with corticosteroids. J Immunol 1992;149:3078\u20133082.", "ArticleIdList": ["1401932"]}, {"Citation": "Arsalane K, Gosset P, Vanhee D, Voisin C, Hamid Q, Tonnel AB, Wallaert B. Ozone stimulates synthesis of inflammatory cytokines by alveolar macrophages in vitro. Am J Respir Cell Mol Biol 1995;13:60\u201368.", "ArticleIdList": ["7598938"]}, {"Citation": "Jarjour NN, Busse WW. Cytokines in bronchoalveolar lavage fluid of patients with nocturnal asthma. Am J Respir Crit Care Med 1995;152:1474\u20131477.", "ArticleIdList": ["7582279"]}, {"Citation": "Sousa AR, Lane SJ, Nakhosteen JA, Lee TH, Poston RN. Expression of interleukin-1 beta (IL-1beta) and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium. Am J Respir Crit Care Med 1996;154:1061\u20131066.", "ArticleIdList": ["8887608"]}, {"Citation": "Pendino KJ, Shuler RL, Laskin JD, Laskin DL. Enhanced production of interleukin-1, tumor necrosis factor-alpha, and fibronectin by rat lung phagocytes following inhalation of a pulmonary irritant. Am J Respir Cell Mol Biol 1994;11:279\u2013286.", "ArticleIdList": ["8086166"]}, {"Citation": "Cohen MD, Sisco M, Li Y, Zelikoff JT, Schlesinger RB. Ozone-induced modulation of cell-mediated immune responses in the lungs. Toxicol Appl Pharmacol 2001;171:71\u201384.", "ArticleIdList": ["11222083"]}, {"Citation": "Fakhrzadeh L, Laskin JD, Laskin DL. Ozone-induced production of nitric oxide and TNF-alpha and tissue injury are dependent on NF-kappaB p50. Am J Physiol Lung Cell Mol Physiol 2004;287:L279\u2013L285.", "ArticleIdList": ["15064226"]}, {"Citation": "Polosa R, Sapsford RJ, Dokic D, Cacciola RR, Prosperini G, Devalia JL, Holgate ST, Howarth PH, Davies DE. Induction of the epidermal growth factor receptor and its ligands in nasal epithelium by ozone. J Allergy Clin Immunol 2004;113:120\u2013126.", "ArticleIdList": ["14713916"]}, {"Citation": "Park JW, Taube C, Swasey C, Kodama T, Joetham A, Balhorn A, Takeda K, Miyahara N, Allen CB, Dakhama A, et al. Interleukin-1 receptor antagonist attenuates airway hyperresponsiveness following exposure to ozone. Am J Respir Cell Mol Biol 2004;30:830\u2013836.", "ArticleIdList": ["14754758"]}, {"Citation": "Johnston RA, Mizgerd JP, Flynt L, Quinton LJ, Williams ES, Shore SA. Type I interleukin-1 receptor is required for pulmonary responses to subacute ozone exposure in mice. Am J Respir Cell Mol Biol 2007;37:477\u2013484.", "ArticleIdList": ["PMC2176124", "17575079"]}, {"Citation": "Dripps DJ, Brandhuber BJ, Thompson RC, Eisenberg SP. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. J Biol Chem 1991;266:10331\u201310336.", "ArticleIdList": ["1828071"]}, {"Citation": "Sato K, Kawana M, Nonomura N, Nakano Y. Course of IL-1beta, IL-6, IL-8, and TNF-alpha in the middle ear fluid of the guinea pig otitis media model induced by nonviable Haemophilus influenzae. Ann Otol Rhinol Laryngol 1999;108:559\u2013563.", "ArticleIdList": ["10378523"]}, {"Citation": "Belmonte KE, Fryer AD, Costello RW. Role of insulin in antigen-induced airway eosinophilia and neuronal M2 muscarinic receptor dysfunction. J Appl Physiol 1998;85:1708\u20131718.", "ArticleIdList": ["9804573"]}, {"Citation": "Wagner EM, Jacoby DB. Methacholine causes reflex bronchoconstriction. J Appl Physiol 1999;86:294\u2013297.", "ArticleIdList": ["9887142"]}, {"Citation": "Fryer AD, Stein LH, Nie Z, Curtis DE, Evans CM, Hodgson ST, Jose PJ, Belmonte KE, Fitch E, Jacoby DB. Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction. J Clin Invest 2006;116:228\u2013236.", "ArticleIdList": ["PMC1319219", "16374515"]}, {"Citation": "Lewis DM, Loegering DA, Gleich GJ. Antiserum to the major basic protein of guinea pig eosinophil granules. Immunochemistry 1976;13:743\u2013746.", "ArticleIdList": ["62707"]}, {"Citation": "Verbout NG, Lorton JK, Jacoby DB, Fryer AD. Atropine pretreatment enhances airway hyperreactivity in antigen-challenged guinea pigs through an eosinophil-dependent mechanism. Am J Physiol Lung Cell Mol Physiol 2007;292:L1126\u2013L1135.", "ArticleIdList": ["17220376"]}, {"Citation": "Tuder RM, Zhen L, Cho CY, Taraseviciene-Stewart L, Kasahara Y, Salvemini D, Voelkel NF, Flores SC. Oxidative stress and apoptosis interact and cause emphysema due to vascular endothelial growth factor receptor blockade. Am J Respir Cell Mol Biol 2003;29:88\u201397.", "ArticleIdList": ["12600822"]}, {"Citation": "Kurt-Jones EA, Beller DI, Mizel SB, Unanue ER. Identification of a membrane-associated interleukin 1 in macrophages. Proc Natl Acad Sci USA 1985;82:1204\u20131208.", "ArticleIdList": ["PMC397223", "3919388"]}, {"Citation": "Watanabe N, Kobayashi Y. Selective release of a processed form of interleukin 1 alpha. Cytokine 1994;6:597\u2013601.", "ArticleIdList": ["7893968"]}, {"Citation": "Dokic D, Howarth HP. Effects of ozone on the nasal mucosa (epithelial cells). Prilozi 2006;27:115\u2013125.", "ArticleIdList": ["17211296"]}, {"Citation": "Gambone LM, Elbon CL, Fryer AD. Ozone-induced loss of neuronal M2 muscarinic receptor function is prevented by cyclophosphamide. J Appl Physiol 1994;77:1492\u20131499.", "ArticleIdList": ["7836157"]}, {"Citation": "Minette PA, Lammers JW, Dixon CM, McCusker MT, Barnes PJ. A muscarinic agonist inhibits reflex bronchoconstriction in normal but not in asthmatic subjects. J Appl Physiol 1989;67:2461\u20132465.", "ArticleIdList": ["2606854"]}, {"Citation": "Fryer AD, Jacoby DB. Parainfluenza virus infection damages inhibitory M2 muscarinic receptors on pulmonary parasympathetic nerves in the guinea-pig. Br J Pharmacol 1991;102:267\u2013271.", "ArticleIdList": ["PMC1917879", "1646059"]}, {"Citation": "Lein PJ, Fryer AD. Organophosphorus insecticides induce airway hyperreactivity by decreasing neuronal M2 muscarinic receptor function independent of acetylcholinesterase inhibition. Toxicol Sci 2005;83:166\u2013176.", "ArticleIdList": ["15470232"]}, {"Citation": "Elbon CL, Jacoby DB, Fryer AD. Pretreatment with an antibody to interleukin-5 prevents loss of pulmonary M2 muscarinic receptor function in antigen-challenged guinea pigs. Am J Respir Cell Mol Biol 1995;12:320\u2013328.", "ArticleIdList": ["7873198"]}, {"Citation": "Zhang XY, Robinson NE, Zhu FX. Modulation of ACh release from airway cholinergic nerves in horses with recurrent airway obstruction. Am J Physiol 1999;276:L769\u2013L775.", "ArticleIdList": ["10330033"]}, {"Citation": "Larsen GL, White CW, Takeda K, Loader JE, Nguyen DD, Joetham A, Groner Y, Gelfand EW. Mice that overexpress Cu/Zn superoxide dismutase are resistant to allergen-induced changes in airway control. Am J Physiol Lung Cell Mol Physiol 2000;279:L350\u2013L359.", "ArticleIdList": ["10926559"]}, {"Citation": "Haddad EB, Rousell J, Lindsay MA, Barnes PJ. Synergy between tumor necrosis factor alpha and interleukin 1beta in inducing transcriptional down-regulation of muscarinic M2 receptor gene expression. Involvement of protein kinase A and ceramide pathways. J Biol Chem 1996;271:32586\u201332592.", "ArticleIdList": ["8955085"]}, {"Citation": "Costello RW, Schofield BH, Kephart GM, Gleich GJ, Jacoby DB, Fryer AD. Localization of eosinophils to airway nerves and effect on neuronal M2 muscarinic receptor function. Am J Physiol 1997;273:L93\u2013L103.", "ArticleIdList": ["9252545"]}, {"Citation": "Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003;167:199\u2013204.", "ArticleIdList": ["12406833"]}, {"Citation": "Noga O, Englmann C, Hanf G, Grutzkau A, Seybold J, Kunkel G. The production, storage and release of the neurotrophins nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 by human peripheral eosinophils in allergics and non-allergics. Clin Exp Allergy 2003;33:649\u2013654.", "ArticleIdList": ["12752594"]}, {"Citation": "Zheng X, Knight DA, Zhou D, Weir T, Peacock C, Schellenberg RR, Bai TR. Leukemia inhibitory factor is synthesized and released by human eosinophils and modulates activation state and chemotaxis. J Allergy Clin Immunol 1999;104:136\u2013144.", "ArticleIdList": ["10400851"]}, {"Citation": "Giembycz MA, Lindsay MA. Pharmacology of the eosinophil. Pharmacol Rev 1999;51:213\u2013340.", "ArticleIdList": ["10353986"]}, {"Citation": "Ollerenshaw SL, Jarvis D, Sullivan CE, Woolcock AJ. Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics. Eur Respir J 1991;4:673\u2013682.", "ArticleIdList": ["1716217"]}, {"Citation": "Hazbun ME, Hamilton R, Holian A, Eschenbacher WL. Ozone-induced increases in substance P and 8-epi-prostaglandin F2 alpha in the airways of human subjects. Am J Respir Cell Mol Biol 1993;9:568\u2013572.", "ArticleIdList": ["7692898"]}, {"Citation": "Wu ZX, Satterfield BE, Dey RD. Substance P released from intrinsic airway neurons contributes to ozone-enhanced airway hyperresponsiveness in ferret trachea. J Appl Physiol 2003;95:742\u2013750.", "ArticleIdList": ["12730146"]}, {"Citation": "Canning BJ, Reynolds SM, Anukwu LU, Kajekar R, Myers AC. Endogenous neurokinins facilitate synaptic transmission in guinea pig airway parasympathetic ganglia. Am J Physiol Regul Integr Comp Physiol 2002;283:R320\u2013R330.", "ArticleIdList": ["12121843"]}, {"Citation": "Lundberg JM, Hokfelt T, Martling CR, Saria A, Cuello C. Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res 1984;235:251\u2013261.", "ArticleIdList": ["6200231"]}, {"Citation": "Hazari MS, Jacoby DB, Fryer AD. Neurokinin NK1 receptor antagonists prevent vagally-induced hyperresponsiveness in ozone exposed guinea pigs [abstract]. Am J Respir Crit Care Med 2003;167."}, {"Citation": "Hurst SM, Stanisz AM, Sharkey KA, Collins SM. Interleukin 1 beta-induced increase in substance P in rat myenteric plexus. Gastroenterology 1993;105:1754\u20131760.", "ArticleIdList": ["7504644"]}, {"Citation": "Wu ZX, Satterfield BE, Fedan JS, Dey RD. Interleukin-1beta-induced airway hyperresponsiveness enhances substance P in intrinsic neurons of ferret airway. Am J Physiol Lung Cell Mol Physiol 2002;283:L909\u2013L917.", "ArticleIdList": ["12376343"]}, {"Citation": "Frossard N, Naline E, Olgart Hoglund C, Georges O, Advenier C. Nerve growth factor is released by IL-1beta and induces hyperresponsiveness of the human isolated bronchus. Eur Respir J 2005;26:15\u201320.", "ArticleIdList": ["15994384"]}, {"Citation": "de Vries A, Engels F, Henricks PA, Leusink-Muis T, McGregor GP, Braun A, Groneberg DA, Dessing MC, Nijkamp FP, Fischer A. Airway hyper-responsiveness in allergic asthma in guinea-pigs is mediated by nerve growth factor via the induction of substance P: a potential role for trkA. Clin Exp Allergy 2006;36:1192\u20131200.", "ArticleIdList": ["16961720"]}, {"Citation": "Gryparis A, Forsberg B, Katsouyanni K, Analitis A, Touloumi G, Schwartz J, Samoli E, Medina S, Anderson HR, Niciu EM, et al. Acute effects of ozone on mortality from the \u201cair pollution and health: a European approach\u201d project. Am J Respir Crit Care Med 2004;170:1080\u20131087.", "ArticleIdList": ["15282198"]}, {"Citation": "Zanobetti A, Schwartz J. Mortality displacement in the association of ozone with mortality: an analysis of 48 U.S. cities. Am J Respir Crit Care Med 2008;177:184\u2013189.", "ArticleIdList": ["17932375"]}]}], "History": [{"Year": "2008", "Month": "7", "Day": "12", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "12", "Day": "17", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "7", "Day": "12", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "12", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18617681", "PMC2586048", "10.1165/rcmb.2008-0045OC", "2008-0045OC"]}}], "PubmedBookArticle": []}